URGN (UROGEN PHARMA LTD) Institutional Ownership Summary
Based on the latest SEC 13F filings, 3 institutional investors hold URGN (UROGEN PHARMA LTD) with a combined value of $85.89M across 3,667,466 shares. The largest holder is BlackRock, Inc. with a position worth $60.92M (0.00% of their portfolio). 2 funds increased their holdings. 1 fund reduced its position.
Total Institutional Value
$85.89M
Total Shares Held
3,667,466
Institutional Holders
3
13F Institutional Holders
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $60.92M | 0.00% | +0.8% |
| 2 | CITADEL ADVISORS LLC | $19.25M | 0.00% | +4.8% |
| 3 | RENAISSANCE TECHNOLOGIES LLC | $5.72M | 0.01% | -11.2% |